Queen Elizabeth II Health Sciences Centre
Quick facts
Marketed products
- oral hypoglycemic agents · Diabetes
Oral hypoglycemic agents lower blood glucose levels through various mechanisms including insulin secretion stimulation, insulin sensitivity improvement, or glucose absorption reduction.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: